The article is available online from Trends in Biotechnology. A preprint is also available from BioRxiv. GenoFAB is a synthetic biology platform dedicated to helping life scientists write and ...

The publication introduces a genetic identification system that enables plasmids to carry embedded documentation, improving traceability, verification, and secure exchange in biotech research and ...

AI evolves beyond mere algorithms to open up new frontiers in generative AI and agentic AI, and the art of the possible is ...

and debate the latest trends in biotech. Additionally, they talk to some of the leading voices in the industry about what's now and next. Start listening today! Stay up to date with the lasted ...

Angelini Ventures, the venture capital arm of Angelini Industries, is a Series A and Series B investment firm focused on accelerating disruptive innovations and trends in biotech and digital health.

Amid a shaky macroeconomic backdrop, biotech stocks have underperformed, with XBI showing poor technical momentum and ...

is a Series A and Series B investment firm focused on accelerating disruptive innovations and trends in biotech and digital health. Angelini Ventures will invest €300 million across a global ...

In an interview with Pharmaceutical Executive, Castro shares his insights on the current funding environment, trends in biotech dealmaking, and how early-stage life sciences companies can position ...

ORI Capital is planning a US$350 million fund to focus on Chinese biotech, with hopes that AI will help beat the market.